Jasmine Nour
Overview
Explore the profile of Jasmine Nour including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Svecla M, Moregola A, Da Dalt L, Nour J, Baragetti A, Uboldi P, et al.
Cardiovasc Diabetol
. 2024 Nov;
23(1):428.
PMID: 39616371
The asialoglycoprotein receptor 1 (ASGR1), a multivalent carbohydrate-binding receptor that primarily is responsible for recognizing and eliminating circulating glycoproteins with exposed galactose (Gal) or N-acetylgalactosamine (GalNAc) as terminal glycan residues,...
2.
Manzo O, Nour J, Sasset L, Marino A, Rubinelli L, Palikhe S, et al.
Circ Res
. 2024 Mar;
134(8):990-1005.
PMID: 38456287
Background: Growing evidence correlated changes in bioactive sphingolipids, particularly S1P (sphingosine-1-phosphate) and ceramides, with coronary artery diseases. Furthermore, specific plasma ceramide species can predict major cardiovascular events. Dysfunction of the...
3.
Svecla M, Da Dalt L, Moregola A, Nour J, Baragetti A, Uboldi P, et al.
Cardiovasc Diabetol
. 2024 Jan;
23(1):42.
PMID: 38281933
Background: Asialoglycoprotein receptor 1 (ASGR1), primarily expressed on hepatocytes, promotes the clearance and the degradation of glycoproteins, including lipoproteins, from the circulation. In humans, loss-of-function variants of ASGR1 are associated...
4.
Bellini R, Moregola A, Nour J, Uboldi P, Bonacina F, Norata G
Immun Inflamm Dis
. 2023 Oct;
11(10):e1024.
PMID: 37904682
Aims: Inflammatory pathways and immune system dysregulation participate in the onset and progression of cardiometabolic diseases. The dendritic cell immunoreceptor 2 (DCIR2) is a C-type lectin receptor mainly expressed by...
5.
Nour J, Bonacina F, Norata G
Atherosclerosis
. 2023 Sep;
384:117277.
PMID: 37775425
Epidemiological data and interventional studies with hormone replacement therapy suggest that women, at least until menopause, are at decreased cardiovascular risk compared to men. Still the molecular mechanisms beyond this...
6.
Bellini R, Moregola A, Nour J, Rombouts Y, Neyrolles O, Uboldi P, et al.
Atheroscler Plus
. 2023 Mar;
51:8-12.
PMID: 36969702
Background And Aims: Atherogenesis results from altered lipid metabolism and impaired immune response. Emerging evidence has suggested that dendritic cells (DCs) participate to atherosclerosis-related immune response, but their impact is...
7.
Nour J, Moregola A, Svecla M, Da Dalt L, Bellini R, Neyrolles O, et al.
Metabolites
. 2022 Dec;
12(12).
PMID: 36557243
The mannose receptor C-type 1 (Mrc1) is a C-type lectin receptor expressed on the immune cells and sinusoidal endothelial cells (ECs) of several tissues, including the bone marrow (BM). Parallel...
8.
Nour J, Moregola A, Molgora M, Mantovani A, Uboldi P, Catapano A, et al.
Thromb Haemost
. 2022 Apr;
122(10):1833-1836.
PMID: 35436796
No abstract available.
9.
Bonacina F, Martini E, Svecla M, Nour J, Cremonesi M, Beretta G, et al.
Cardiovasc Res
. 2020 Sep;
117(9):2069-2082.
PMID: 32931583
Aim: Loss of immunosuppressive response supports inflammation during atherosclerosis. We tested whether adoptive cell therapy (ACT) with Tregulatory cells (Tregs), engineered to selectively migrate in the atherosclerotic plaque, would dampen...